332 related articles for article (PubMed ID: 2110015)
21. Regional differences in the prostanoid receptors mediating prostaglandin F2 alpha-induced contractions of cat isolated arteries.
Nakajima M; Ueda M
Eur J Pharmacol; 1990 Dec; 191(3):359-68. PubMed ID: 2086248
[TBL] [Abstract][Full Text] [Related]
22. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
Arner M; Högestätt ED; Uski TK
Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
[TBL] [Abstract][Full Text] [Related]
23. Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions.
Auch-Schwelk W; Katusic ZS; Vanhoutte PM
Hypertension; 1990 Jun; 15(6 Pt 2):699-703. PubMed ID: 2141003
[TBL] [Abstract][Full Text] [Related]
24. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
Johnson GJ; Dunlop PC; Leis LA; From AH
Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
[TBL] [Abstract][Full Text] [Related]
25. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide.
Tesfamariam B
J Hypertens; 1994 Jan; 12(1):41-7. PubMed ID: 8157943
[TBL] [Abstract][Full Text] [Related]
26. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist.
Hanasaki K; Arita H
Biochim Biophys Acta; 1989 Sep; 1013(1):28-35. PubMed ID: 2528990
[TBL] [Abstract][Full Text] [Related]
27. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
Mais DE; Saussy DL; Magee DE; Williams CM
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():347-50. PubMed ID: 1825567
[No Abstract] [Full Text] [Related]
28. Antiaggregatory effects of thromboxane receptor antagonists in vivo.
Darius H; Lefer AM
Thromb Res; 1985 Dec; 40(5):663-75. PubMed ID: 2935972
[TBL] [Abstract][Full Text] [Related]
29. The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery.
Templeton AG; McGrath JC; Whittle MJ
Br J Pharmacol; 1991 May; 103(1):1079-84. PubMed ID: 1878747
[TBL] [Abstract][Full Text] [Related]
30. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
31. Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism.
Smith JB; Yanagisawa A; Zipkin R; Lefer AM
Prostaglandins; 1987 Jun; 33(6):777-82. PubMed ID: 3671730
[TBL] [Abstract][Full Text] [Related]
32. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
Zehender H; Witte EC; Wolff HP; Patscheke H
Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585
[TBL] [Abstract][Full Text] [Related]
33. Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor.
Mayeux PR; Mais DE; Halushka PV
Eur J Pharmacol; 1991 Jan; 206(1):15-21. PubMed ID: 1712307
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin endoperoxides and thromboxane A2 activate the same receptor isoforms in human platelets.
Vezza R; Mezzasoma AM; Venditti G; Gresele P
Thromb Haemost; 2002 Jan; 87(1):114-21. PubMed ID: 11848439
[TBL] [Abstract][Full Text] [Related]
35. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
Hornberger W; Patscheke H
Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of prostaglandin H2/thromboxane A2 receptors: distinct subtypes mediate vascular smooth muscle contraction and platelet aggregation.
Furci L; Fitzgerald DJ; Fitzgerald GA
J Pharmacol Exp Ther; 1991 Jul; 258(1):74-81. PubMed ID: 1830100
[TBL] [Abstract][Full Text] [Related]
37. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction.
Lin L; Nasjletti A
Hypertension; 1991 Aug; 18(2):158-64. PubMed ID: 1885223
[TBL] [Abstract][Full Text] [Related]
38. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
[No Abstract] [Full Text] [Related]
39. 15-Hydroxyeicosatetraenoic acid and diabetic endothelial dysfunction in rabbit aorta.
Tesfamariam B; Brown ML; Cohen RA
J Cardiovasc Pharmacol; 1995 May; 25(5):748-55. PubMed ID: 7630153
[TBL] [Abstract][Full Text] [Related]
40. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
Mais DE; Kochel PJ; Saussy DL; Halushka PV
Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]